IBDEI1VL ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31860,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,31860,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,31861,0)
 ;;=E11.59^^126^1607^18
 ;;^UTILITY(U,$J,358.3,31861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31861,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Compl NEC
 ;;^UTILITY(U,$J,358.3,31861,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,31861,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,31862,0)
 ;;=E11.610^^126^1607^27
 ;;^UTILITY(U,$J,358.3,31862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31862,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropath Arthropathy
 ;;^UTILITY(U,$J,358.3,31862,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,31862,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,31863,0)
 ;;=E11.618^^126^1607^22
 ;;^UTILITY(U,$J,358.3,31863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31863,1,3,0)
 ;;=3^DM Type 2 w/ Diab Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,31863,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,31863,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,31864,0)
 ;;=E11.620^^126^1607^24
 ;;^UTILITY(U,$J,358.3,31864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31864,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,31864,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,31864,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,31865,0)
 ;;=E11.622^^126^1607^34
 ;;^UTILITY(U,$J,358.3,31865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31865,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,31865,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,31865,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,31866,0)
 ;;=E11.628^^126^1607^33
 ;;^UTILITY(U,$J,358.3,31866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31866,1,3,0)
 ;;=3^DM Type 2 w/ Skin Compl NEC
 ;;^UTILITY(U,$J,358.3,31866,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,31866,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,31867,0)
 ;;=E11.69^^126^1607^19
 ;;^UTILITY(U,$J,358.3,31867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31867,1,3,0)
 ;;=3^DM Type 2 w/ Complications NEC
 ;;^UTILITY(U,$J,358.3,31867,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,31867,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,31868,0)
 ;;=E11.8^^126^1607^20
 ;;^UTILITY(U,$J,358.3,31868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31868,1,3,0)
 ;;=3^DM Type 2 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,31868,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,31868,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,31869,0)
 ;;=E10.51^^126^1607^13
 ;;^UTILITY(U,$J,358.3,31869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31869,1,3,0)
 ;;=3^DM Type 1 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,31869,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,31869,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,31870,0)
 ;;=E10.52^^126^1607^12
 ;;^UTILITY(U,$J,358.3,31870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31870,1,3,0)
 ;;=3^DM Type 1 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,31870,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,31870,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,31871,0)
 ;;=E10.59^^126^1607^1
 ;;^UTILITY(U,$J,358.3,31871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31871,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Compl NEC
 ;;^UTILITY(U,$J,358.3,31871,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,31871,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,31872,0)
 ;;=E10.610^^126^1607^10
 ;;^UTILITY(U,$J,358.3,31872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31872,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathy Arthropathy
 ;;^UTILITY(U,$J,358.3,31872,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,31872,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,31873,0)
 ;;=E10.618^^126^1607^5
 ;;^UTILITY(U,$J,358.3,31873,1,0)
 ;;=^358.31IA^4^2
